Access to effective psychosocial treatment for psychosis continues to be elusive in the United States. For years, the literal and figurative costs associated with the diagnosis of schizophrenia have been known, policies to promote improved national mental healthcare have been in place and recommendations for evidence-based treatments have existed. And yet, the implementation and uptake of such policies and recommendations within psychosis treatment have only been moderately successful because clinicians have been overlooked as agents of change. Continuous development and transmission of the latest evidence and practices for psychosocial treatments for psychosis are essential, but so is the support of the individual clinicians who will implement them. The path forward must attack this problem from a number of directions and can follow the recommendations put forth by the President’s New Freedom Commission. We conclude with concrete action steps individual providers can take to facilitate change.